Search - tctmd.com

Displaying 561 - 580 of 673

Sort: Relevancy | Date

Presentation CHIP Seattle 2017

CHIP Case Discussion: Underthinking + Overthinking in the Same Case

Presenter: Ajay J. Kirtane

August 11, 2017

Presentation

Optimized Screening of CAD With Invasive Coronary Angiography and Ad Hoc PCI During TAVR

August 10, 2017

News Daily News

Ad Hoc PCI Safe and Feasible in Patients Undergoing TAVR

Leah Lawrence

August 10, 2017

Manuscript

Acute Hemodynamic Changes after Mitraclip Implantation Comparing Patients with Degenerative and Functional Mitral Regurgitation

August 07, 2017

News Features

A Heart to Hold: 3-D Printers Add New Dimension to the Treatment of Structural Cardiac Disease

Yael L. Maxwell

August 02, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2017

Shelley Wood

July 31, 2017

News Daily News

Newly Proposed Classification of AS Focuses on Baseline Cardiac Damage as Outcome Predictor

L.A. McKeown

July 26, 2017

Podcast Heart Sounds

CV Risk Higher With Modestly Elevated Troponin Levels, but Clinical Relevance Remains Unclear

Todd Neale

July 24, 2017

Presentation LAA 2017

Left Atrial Appendage Occlusion as Adjunctive Therapy

Presenter: Amar Krishnaswamy

July 21, 2017

Podcast

Episode 15: BRS, Left Main PCI, PFO Closure, and More

July 19, 2017

News Daily News

Mystery of Global Bacterial Outbreak Among Cardiothoracic Surgery Patients Solved With Genomic Sequencing

L.A. McKeown

July 14, 2017

News Daily News

More Vascular Complications, Higher 30-Day Mortality With PCI Prior to TAVR: Meta-Analysis

Michael O'Riordan

July 03, 2017

News Daily News

TCTMD’s Top 10 Most Popular Stories for June 2017

Shelley Wood

July 03, 2017

Manuscript

Prognostic Value of Combination of Hemodynamic Parameters in Asymptomatic Aortic Valve Stenosis—The COFRASA/GENERAC Study

June 09, 2017

Podcast

Episode 14: ABSORB II, the Future of BRS, and Post-TAVR Thrombosis

June 07, 2017

News Conference News EuroPCR 2017

My Takeaways From EuroPCR 2017: Everything Perfect, Until It’s Not

Shelley Wood

June 02, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2017

Shelley Wood

June 01, 2017

News Industry News

Medtronic RESOLUTE ONYX(TM) 2.0 mm Clinical Study Meets Primary Endpoint in Extra-Small Vessels at One-Year

May 18, 2017

Presentation EuroPCR 2017

Efficacy and Safety of LAA Closure with WATCHMAN in Patients with or without Contraindication to Oral Anticoagulation: 1-year FU of the EWOLUTION trial

Presenter: Lucas Boersma, Martin W. Bergmann

May 18, 2017

Advertisement

CHIP Case Discussion: Underthinking + Overthinking in the Same Case

Optimized Screening of CAD With Invasive Coronary Angiography and Ad Hoc PCI During TAVR

Ad Hoc PCI Safe and Feasible in Patients Undergoing TAVR

Acute Hemodynamic Changes after Mitraclip Implantation Comparing Patients with Degenerative and Functional Mitral Regurgitation

A Heart to Hold: 3-D Printers Add New Dimension to the Treatment of Structural Cardiac Disease

TCTMD’s Top 10 Most Popular Stories for July 2017

Newly Proposed Classification of AS Focuses on Baseline Cardiac Damage as Outcome Predictor

Top Stories in Cardiology, July 2017

CV Risk Higher With Modestly Elevated Troponin Levels, but Clinical Relevance Remains Unclear

Left Atrial Appendage Occlusion as Adjunctive Therapy

Episode 15: BRS, Left Main PCI, PFO Closure, and More

Mystery of Global Bacterial Outbreak Among Cardiothoracic Surgery Patients Solved With Genomic Sequencing

More Vascular Complications, Higher 30-Day Mortality With PCI Prior to TAVR: Meta-Analysis

TCTMD’s Top 10 Most Popular Stories for June 2017

Prognostic Value of Combination of Hemodynamic Parameters in Asymptomatic Aortic Valve Stenosis—The COFRASA/GENERAC Study

Episode 14: ABSORB II, the Future of BRS, and Post-TAVR Thrombosis

My Takeaways From EuroPCR 2017: Everything Perfect, Until It’s Not

TCTMD’s Top 10 Most Popular Stories for May 2017

Medtronic RESOLUTE ONYX(TM) 2.0 mm Clinical Study Meets Primary Endpoint in Extra-Small Vessels at One-Year

Efficacy and Safety of LAA Closure with WATCHMAN in Patients with or without Contraindication to Oral Anticoagulation: 1-year FU of the EWOLUTION trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content